Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H31O15.Cl |
Molecular Weight | 630.979 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C([O+]=C4C=C(O)C=C(O)C4=C3)C5=CC=C(O)C(O)=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
InChI
InChIKey=ADZHXBNWNZIHIX-XYGAWYNKSA-N
InChI=1S/C27H30O15.ClH/c1-9-19(32)21(34)23(36)26(39-9)38-8-18-20(33)22(35)24(37)27(42-18)41-17-7-12-14(30)5-11(28)6-16(12)40-25(17)10-2-3-13(29)15(31)4-10;/h2-7,9,18-24,26-27,32-37H,8H2,1H3,(H3-,28,29,30,31);1H/t9-,18+,19-,20+,21+,22-,23+,24+,26+,27+;/m0./s1
Molecular Formula | C27H30O15 |
Molecular Weight | 594.5181 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Keracyanin (antirrhinin) is the pigment originally isolated from the fruit of the cherry. The compound exerts potent antioxidant properties. It is able to inhibit host- and bacteria-derived proteinases. Dietary supplementation with purified keracyanin suppresses body weight gain in high-fat diet fed mice.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24930424 |
|||
Target ID: GO:0008283 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20155622 |
|||
Target ID: GO:0006915 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20155622 |
|||
Target ID: CHEMBL332 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21517858 |
|||
Target ID: CHEMBL321 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21517858 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6381579 |
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Studies on anthocyanins. XXIV. Keracyanin, a pigment in the fire-red blooms of Canna generalis]. | 1954 Mar |
|
Dose-modifying effect of a cyanidine chloride derivative, keracyanin, for uv irradiation of murine L fibroblasts cultured in vitro. | 1979 Mar |
|
[Experimental study of the effects of cyaninoside chloride on collagen, and its potential value in ophthalmology]. | 1984 |
|
[Effects of cyaninoside chloride and Heleniene on mesopic and scotopic vision in myopia and night blindness]. | 1984 |
|
Oral flavonoids, chromocarb diethylamine salt and cyaninosides chloride, to eliminate lipoperoxidation postvitrectomy. | 2002 Jan |
|
Inhibition of malonaldehyde formation in oxidized calf thymus DNA with synthetic and natural antioxidants. | 2004 Sep 8 |
|
Formation and inhibition of genotoxic malonaldehyde from DNA oxidation controlled with EDTA. | 2006 Feb |
|
Inhibition of host- and bacteria-derived proteinases by natural anthocyanins. | 2011 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23768383
The results from a 12-week experiment show that consumption of purified mulberry anthocyanin cyanidin-3-O-rutinoside (keracyanin) of 40 or 200mg/kg can significantly inhibit body weight gain, reduce the resistance to insulin, lower the size of adipocytes, attenuate lipid accumulation and decrease the leptin secretion.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20155622
The effects of cyanidin-3-O-rutinoside (keracyanin), on the growth of RE-149 and RE-149 DHD cells were determined at concentrations ranging from 10–50 µg/ ml
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:02:36 GMT 2023
by
admin
on
Sat Dec 16 17:02:36 GMT 2023
|
Record UNII |
V0N2VMB4FV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C275
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
||
|
NCI_THESAURUS |
C1745
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
242-528-6
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
3580
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
ANTIRRHININ
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL505251
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
m3947
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
28165
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
ALTERNATIVE | |||
|
SUB77256
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
C81330
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
100000082847
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
16726
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
236274
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
V0N2VMB4FV
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
V0N2VMB4FV
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
18719-76-1
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
3975
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
DTXSID00927864
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
28064
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
29231
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY | |||
|
SUB08364MIG
Created by
admin on Sat Dec 16 17:02:36 GMT 2023 , Edited by admin on Sat Dec 16 17:02:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Oxygen radical absorbance capacity (ORAC) assays proved high antioxidant activity.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |